{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:24:45Z","timestamp":1755797085524,"version":"3.44.0"},"reference-count":43,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:sec id=\"S1047951125101637_as1\">\n\t    <jats:title>Objective:<\/jats:title>\n\t    <jats:p>A retrospective analysis of paediatric infective endocarditis characterised causative pathogens, antimicrobial susceptibility patterns, and treatment outcomes to guide clinical decision-making.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1047951125101637_as2\">\n\t    <jats:title>Methods:<\/jats:title>\n\t    <jats:p>The data of patients who received infective endocarditis between 2016 and 2023 were retrospectively collected from the medical records database. The clinical characteristics, treatment plans, and pharmaceutical monitoring characteristics were analysed and summarised.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1047951125101637_as3\">\n\t    <jats:title>Results:<\/jats:title>\n\t    <jats:p>A total of 12 paediatric infective endocarditis cases were identified. Bacterial isolates included 27 Gram-positive and 1 Gram-negative strains. The most common pathogen was <jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>n<\/jats:italic> = 13), all methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA), followed by <jats:italic>Abiotrophia defectiva<\/jats:italic> (<jats:italic>n<\/jats:italic> = 6), <jats:italic>Streptococcus mitis<\/jats:italic> (<jats:italic>n<\/jats:italic> = 5), <jats:italic>Streptococcus sanguinis<\/jats:italic> (<jats:italic>n<\/jats:italic> = 2), <jats:italic>Bacillus cereus<\/jats:italic> (<jats:italic>n<\/jats:italic> = 1), and <jats:italic>Klebsiella oxytoca<\/jats:italic> (<jats:italic>n<\/jats:italic> = 1). Antimicrobial therapy primarily involved linezolid, vancomycin, and cephalosporin\/enzyme inhibitor combinations. Cardiac glycosides were used in 10 cases, and all patients received phosphocreatine to support myocardial energy metabolism. Therapeutic drug monitoring for vancomycin was performed in 25% of cases, while no therapeutic drug monitoring was conducted for meropenem or linezolid.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1047951125101637_as4\">\n\t    <jats:title>Conclusion:<\/jats:title>\n\t    <jats:p>All the causative organisms were predominantly Gram-positive cocci, with MRSA accounting for the largest proportion; different streptococci varied considerably in terms of drug resistance. The antimicrobial drugs used were predominantly linezolid and glycopeptides. The rate of blood concentration monitoring was low.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1017\/s1047951125101637","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T12:54:16Z","timestamp":1755521656000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Drug treatment analysis of infective endocarditis in children\u2014a retrospective, single-centre study"],"prefix":"10.1017","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0118-7236","authenticated-orcid":false,"given":"Sanni","family":"Li","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital of Hebei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Hebei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Hebei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Hebei"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"S1047951125101637_ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-01959-3"},{"key":"S1047951125101637_ref12","doi-asserted-by":"publisher","DOI":"10.15829\/1560-4071-2016-5-65-116"},{"key":"S1047951125101637_ref37","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11121431"},{"key":"S1047951125101637_ref33","first-page":"1081","article-title":"Chinese medical doctor association cardiovascular internal medicine branch. Expert committee of chinese heart failure center alliance. Chinese expert consensus on clinical application of drugs to improve cardiac metabolism(2021)","volume":"40","year":"2021","journal-title":"Chin J Geriatr"},{"key":"S1047951125101637_ref36","first-page":"1057","article-title":"Highlights of the guidelines for diagnosis and treatment of heart failure in China in 2018","volume":"16","author":"Yang","year":"2018","journal-title":"Chin J Cardiovasc Res"},{"key":"S1047951125101637_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2016.12.020"},{"key":"S1047951125101637_ref32","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2022.04.201450"},{"key":"S1047951125101637_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-022-02509-3"},{"key":"S1047951125101637_ref43","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad168"},{"key":"S1047951125101637_ref11","first-page":"913","article-title":"Society of pediatrics, chinese medical, association, etal, recommendation for diagnostic criteria for infectious endocarditis in children.","volume":"48","year":"2010","journal-title":"Chin J Pediatr"},{"key":"S1047951125101637_ref3","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003110"},{"key":"S1047951125101637_ref30","first-page":"78","article-title":"Therapeutic effect of phosphocreatine on heart function and plasma BNP level in patients with chronic heart failure","volume":"42","author":"Chen","year":"2015","journal-title":"Chin J Pract Med"},{"key":"S1047951125101637_ref41","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2010.0383"},{"key":"S1047951125101637_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw129"},{"key":"S1047951125101637_ref6","doi-asserted-by":"publisher","DOI":"10.36347\/sasjm.2022.v08i10.003"},{"key":"S1047951125101637_ref34","first-page":"84","article-title":"Recommendations for diagnosis and treatment of heart failure in children (2020 revised edition)","volume":"59","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"S1047951125101637_ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.204693"},{"key":"S1047951125101637_ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000013073.22415.90"},{"key":"S1047951125101637_ref8","first-page":"11","volume-title":"The Sanford Guide to Antimicrobial Therapy 2020","author":"David","year":"2021"},{"key":"S1047951125101637_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(00)00194-2"},{"key":"S1047951125101637_ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1040778"},{"key":"S1047951125101637_ref26","doi-asserted-by":"publisher","DOI":"10.1086\/381098"},{"key":"S1047951125101637_ref21","first-page":"7050257","article-title":"Abiotrophia defectiva infective endocarditis: a rare and dangerous cause of endocarditis","volume":"2022","author":"Lancaster","year":"2022","journal-title":"Case Rep Infect Dis"},{"key":"S1047951125101637_ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10173-y"},{"key":"S1047951125101637_ref28","first-page":"003702","article-title":"Abiotrophia defectiva endocarditis: a rare cause with aggressive systemic embolisation and need of valve replacement","volume":"10","author":"Cochicho Ramalho","year":"2023","journal-title":"Eur J Case Rep Intern Med"},{"key":"S1047951125101637_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.01.014"},{"first-page":"32","volume-title":"Expert Committee on Rational Use of Medicines of the National Health and Health Commission","year":"2023","key":"S1047951125101637_ref14"},{"volume-title":"Manual of Childhood Infections: The Blue Book","year":"2016","author":"Sharland","key":"S1047951125101637_ref1"},{"key":"S1047951125101637_ref10","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00028-14"},{"key":"S1047951125101637_ref25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.9.4323-4326.2004"},{"key":"S1047951125101637_ref17","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01861-22"},{"key":"S1047951125101637_ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000298"},{"key":"S1047951125101637_ref13","article-title":"Infective endocarditis: comments on the 2023 Duke-international society for cardiovascular infectious diseases criteria for infective endocarditis: updating the modified Duke criteria","volume":"8","author":"Lamas","year":"2023","journal-title":"HVT"},{"key":"S1047951125101637_ref20","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801812010028"},{"key":"S1047951125101637_ref39","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn311365-20200731-00732"},{"key":"S1047951125101637_ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02100-4"},{"key":"S1047951125101637_ref27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02645-15"},{"key":"S1047951125101637_ref5","first-page":"e31747","article-title":"The incidence and clinical characteristics of infective endocarditis in children: a five-year, single-centre retrospective evaluation","volume":"14","author":"Yilmaz","year":"2022","journal-title":"Cureus"},{"key":"S1047951125101637_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.04.030"},{"key":"S1047951125101637_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.4.945"},{"key":"S1047951125101637_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2014.01.002"},{"key":"S1047951125101637_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.05.011"},{"key":"S1047951125101637_ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-015-0104-2"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951125101637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T12:54:19Z","timestamp":1755521659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951125101637\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":43,"alternative-id":["S1047951125101637"],"URL":"https:\/\/doi.org\/10.1017\/s1047951125101637","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"type":"print","value":"1047-9511"},{"type":"electronic","value":"1467-1107"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}